Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Dr Seint Lwin, a postdoctoral researcher in Dr James Edwards's group at NDORMS has been selected to present her science to Parliament, as part of the 2015 SET for Britain competition on 9 March.

Dr Seint Lwin, a postdoctoral researcher in Dr James Edwards's group at NDORMS has been selected to present her science to Parliament, as part of the 2015 SET for Britain competition on 9 March.

Seint is working on how diet manipulation affects ageing, cancer, and skeletal health. On presenting her science in Parliament, she said: "I am excited to be able to share our work at this wonderful event, promoting the breadth and depth of scientific research across the UK. Our work highlights how simple dietary modifications may produce substantial health benefits, and I look forward to the opportunity to network with other scientists and build bridges across different scientific disciplines."

The overall aim of SET for Britain is to encourage, support and promote Britain's early-stage and early-career researchers who are key to the UK’s continued progress in and development of R&D.

Researchers are shortlisted from hundreds of applicants to appear in Parliament and judged by leading academics against dozens of other peers in the only national competition of its kind.

Seint’s research has been entered into the Biological and Biomedical Sciences session of the competition, which will end in a gold, silver and bronze prize-giving ceremony. The gold medalist receives £3,000, while silver and bronze receive £2,000 and £1,000 respectively.

More information on SET for Britain here.

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.